300194.SZ
300194.SZ
CNE1000011G4
FUAN PHARM
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 1.738.291.062 2.391.468.105
27.3%
Cost of Revenue 1.095.715.331 1.124.997.486
2.6%
Gross Profit 642.575.732 1.266.470.619
49.3%
546.200.361 958.291.146
43.0%
Operating Income 96.375.370 308.179.473
68.7%
Pretax Income 83.243.576 312.196.554
73.3%
Net Income Common Stockholders 76.997.130 279.837.281
72.5%
-- --
--
-- --
--
ende